The Clinical Outcomes for Glycemic Control in Diabetic Patients during the Prevention of Covid-19 Pandemic at Rong Kham Hospital Kalasin Province
Abstract
Abstract
From the situation of the epidemic of Covid-19 in 2021, Rong Kham Hospital There has been a project to send medicines home to some chronic disease patients voluntarily. To reduce congestion and prevent the epidemic of Covid-19 according to the policy "Stay at home, stop germs, for the nation" It has started to be delivered at home by a team of family doctors. and home health volunteers from October 1, 2020.
In 2021, medicines will be delivered to patients at home 1-2 times per appointment, which does not require a visit to the doctor for approximately 3-6 months.
Objective of this study was to compare the clinical outcomes in diabetic control of diabetic patients between the hospital admission in 2020 and the home treatment diabetic patients in 2021.Data were analyzed by descriptive and paired statistics. t-test in statistical analysis The level of significance was set at 0.05.
The results: The proportion of diabetic patients with HbA1C <7 %, FBS <130 mg/dL, LDL<100 mg/dL, eGFR ≥90 ml/min/1.73 m2 in 2020 was 16 %, 29.2 %, 74.5 % and 44.9 %, respectively, and the proportion of diabetic patients with HbA1C <7 %, FBS <130 mg/dl, LDL<100 mg/dl, eGFR ≥90 ml. /min/1.73 m2 in 2021 is 8.9 %, 37.4 %, 65.8 %, and 39.1 % respectively.
Comparing the mean clinical outcomes for diabetes control between the hospital admission in 2020 and the home admission in 2021, it was found that the mean HbA1C, LDL and eGFR levels between There was a difference between the time diabetic patients receiving medicine at the hospital in 2020 and the time when diabetic patients receiving medicine at home in 2021 (p = 0.291, p = 0.001 and p = 0.008, respectively). There was no significant difference in the pre-morning blood glucose (FBS) between the hospital admission of diabetic patients in 2020 and that of the diabetic patient receiving medication at home in 2021 (p = 0.579) is an opportunity to develop a home delivery system to reduce congestion in hospitals Reduce patient travel expenses Which should continue to follow up care in the future.
Keywords : Diabetes mellitus, Home drug delivery, COVID-19
